Now Enrolling: Psoriatic Arthritis / Tirzepatide Research Study
Serving Houston & Surrounding Areas
You may qualify for a local clinical research study involving Tirzepatide, a medication being evaluated for its potential impact on inflammation and weight loss.
Compensation Available for Qualified Participants
Call Now: (832) 924-2863
Houston Residents
Fill out the short form below to see if you qualify — our staff will follow up. 2-3 Months On Taltz Is Necessary
This is a no-cost opportunity to contribute to future advancements in rheumatology care — and get support along the way.
Tirzepatide is a promising investigational medication originally developed for weight management and type 2 diabetes. Researchers are now studying its potential benefits for autoimmune and inflammatory conditions — including Psoriatic Arthritis.
In some cases, weight reduction may also support symptom improvement and joint health.
Led by board-certified rheumatologist Dr. Tamar Brionez, our clinic brings over a decade of experience treating complex autoimmune and musculoskeletal conditions. You’ll receive care in a professional, supportive environment dedicated to advancing research and improving quality of life.
Located at: 10857 Kuykendahl Rd, Suite 160, Spring, TX 77382
Questions? Call (832) 924-2863 or email info@advancedrheum.com
You may qualify for a local clinical research study involving Tirzepatide, a medication being evaluated for its potential impact on inflammation and weight loss.
(281) 766-7886 | info@advancedrheum.com | 10857 Kuykendahl Rd, #160, Spring, TX 77382
©2025 Advanced Rheumatology of Houston. All rights reserved.